Granulomatous hepatitis, choroiditis and aortoduodenal fistula complicating intravesical Bacillus Calmette-Guérin therapy: Case report
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Granulomatous hepatitis, choroiditis and aortoduodenal fistula complicating intravesical Bacillus Calmette-Guérin therapy: Case report ; volume:11 ; number:1 ; day:30 ; month:9 ; year:2011 ; pages:1-6 ; date:12.2011
BMC infectious diseases ; 11, Heft 1 (30.9.2011), 1-6, 12.2011
- Creator
-
Gao, Cindy Q.
- Contributor
-
Mithani, Rozina
Leya, Jack
Dawravoo, Lesley
Bhatia, Arvin
Antoine, John
Alba, Felipe de
Russo, Peter A.
Fimmel, Claus J.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-11-260
- URN
-
urn:nbn:de:1111-2016030261417
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gao, Cindy Q.
- Mithani, Rozina
- Leya, Jack
- Dawravoo, Lesley
- Bhatia, Arvin
- Antoine, John
- Alba, Felipe de
- Russo, Peter A.
- Fimmel, Claus J.
- SpringerLink (Online service)
Other Objects (12)
Granulomatous myocarditis arising from intravesical Bacillus Calmette–Guérin therapy leading to death diagnosed by postmortem examination: a case report
Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
Assessing treatment response after intravesical bacillus Calmette–Guerin induction cycle: are routine bladder biopsies necessary?
Molecular networks discriminating mouse bladder responses to intravesical bacillus Calmette-Guerin (BCG), LPS, and TNF-α
Combined Application of Nivolumab and Intravesical Bacillus Calmette-Guérin Led to Acute-Onset Type 1 Diabetes
Poncet’s disease after the intravesical instillation of Bacillus Calmette–Guérin (BCG): a case report
Durch Bacillus Calmette-Guerin induzierte Tuberkulose
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Intravesical bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: abridged summary of the Cochrane Review
Aortic aneurysm and aortic graft infection related to Mycobacterium bovis after intravesical Bacille Calmette–Guérin therapy—a case series
Granulomatous myocarditis arising from intravesical Bacillus Calmette–Guérin therapy leading to death diagnosed by postmortem examination: a case report
Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
Assessing treatment response after intravesical bacillus Calmette–Guerin induction cycle: are routine bladder biopsies necessary?
Molecular networks discriminating mouse bladder responses to intravesical bacillus Calmette-Guerin (BCG), LPS, and TNF-α
Combined Application of Nivolumab and Intravesical Bacillus Calmette-Guérin Led to Acute-Onset Type 1 Diabetes
Poncet’s disease after the intravesical instillation of Bacillus Calmette–Guérin (BCG): a case report
Durch Bacillus Calmette-Guerin induzierte Tuberkulose
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Intravesical bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: abridged summary of the Cochrane Review
Aortic aneurysm and aortic graft infection related to Mycobacterium bovis after intravesical Bacille Calmette–Guérin therapy—a case series
Granulomatous myocarditis arising from intravesical Bacillus Calmette–Guérin therapy leading to death diagnosed by postmortem examination: a case report
Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG)
Assessing treatment response after intravesical bacillus Calmette–Guerin induction cycle: are routine bladder biopsies necessary?
Molecular networks discriminating mouse bladder responses to intravesical bacillus Calmette-Guerin (BCG), LPS, and TNF-α
Combined Application of Nivolumab and Intravesical Bacillus Calmette-Guérin Led to Acute-Onset Type 1 Diabetes
Poncet’s disease after the intravesical instillation of Bacillus Calmette–Guérin (BCG): a case report
Durch Bacillus Calmette-Guerin induzierte Tuberkulose
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
Intravesical bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: abridged summary of the Cochrane Review